Evidence map›Paper›PMID 32951858›Full record

ArticleTrends in neurosciences2020

This Is Your Brain on (Low) Glucose.

Patrick Miller-Rhodes, Harris A Gelbard, Niccolò Terrando

Open access · greenAbstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Trends in neurosciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Patrick Miller-RhodesCenter for Neurotherapeutics Discovery, University of Rochester Medical Center, Rochester, NY 14642, USA; Department of Neuroscience, University of Rochester Medical Center, Rochester, NY 14642, USA.
Harris A GelbardCenter for Neurotherapeutics Discovery, University of Rochester Medical Center, Rochester, NY 14642, USA; Department of Neuroscience, University of Rochester Medical Center, Rochester, NY 14642, USA; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA; Department of Neurology, University of Rochester Medical Center, Rochester, NY 14642, USA; Department of Pediatrics, University of Rochester Medical Center, Rochester, NY 14642, USA. Electronic address: Harris_Gelbard@URMC.Rochester.edu.
Niccolò TerrandoCenter for Translational Pain Medicine, Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: niccolo.terrando@duke.edu.
University of Rochester Medical Center · USDuke University · US

Funding

Neurovascular dysfunction in delirium superimposed on dementiaR01AG057525 · NIA · DUKE UNIVERSITY · PI Niccolo Terrando · 2017 to 2026
$6.7M
NIA NIH HHS R01 AG057525
6 · The paper itself

Abstract

Brain functioning and high-order cognitive functions critically rely on glucose as a metabolic substrate. In a recent study, Kealy et al. investigated the impact of glucose availability on sickness behavior and delirium in mice and humans. They identified disrupted brain carbohydrate metabolism as a key mechanistic driver of these behaviors.

Indexed as

DeliriumGlucoseAnimalsBrainCognitionEnergy MetabolismHumansInflammationMiceGlucosedeliriumhypoglycemialipopolysaccharideneurodegeneration

Identifiers

PMID32951858
PMCPMC7688553
OpenAlexW3087692878

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.